BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
Phase 2
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: PlaceboDrug: low-dose BXOS110Drug: high-dose BXOS110
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Biocells (Beijing) Biotech Co.,Ltd
- Target Recruit Count
- 300
- Registration Number
- NCT06322394
- Locations
- 🇨🇳
Anyang People's Hospital, Anyang, Henan, China
🇨🇳MeiHekou Central Hospital, Meihekou, Jilin, China
🇨🇳Ceneral Hospital of Mining Industry Group Fuxin, Fuxin, Liaoning, China
© Copyright 2025. All Rights Reserved by MedPath